Chemical Research in Toxicology is a premier journal published by the American Chemical Society, dedicated to advancing the understanding of toxicological effects associated with chemical substances. Since its inception in 1988, this esteemed journal has maintained a robust impact factor, ranking in the Q1 quartile for both Medicine (miscellaneous) and Toxicology as of 2023, reflecting its significance and influence in the fields of pharmacology and toxicology. With an impressive Scopus ranking at #16 out of 133 in the Toxicology category, it serves as a vital resource for researchers, professionals, and students seeking cutting-edge insights and scholarly articles that bridge the gap between chemistry and toxicological science. Although not an open-access publication, it continues to provide comprehensive analyses and original research that inform safe chemical practices and regulatory policies, further enhancing its role in public health and safety.

TOXICOLOGY, published by Elsevier Ireland Ltd, is a prestigious peer-reviewed journal specializing in the field of toxicology. With an ISSN of 0300-483X and an E-ISSN of 1879-3185, this journal provides a vital platform for researchers, professionals, and students to disseminate and access groundbreaking studies from 1973 to present, with a convergence set until 2024. Recognized for its high impact, it holds a Q1 ranking in Toxicology category and ranks #18 out of 133 in Scopus's sector of Pharmacology, Toxicology, and Pharmaceutics, placing it in the 86th percentile. While the journal is not open access, it nonetheless offers a rich collection of research articles that enhance the understanding of toxicological science and its applications. The journal's objectives encompass advancing knowledge in the toxicological evaluation of substances, promoting safety in public health, and fostering dialogue among scholars. As a key resource in the field, TOXICOLOGY plays a crucial role in advancing research and informing practices related to toxicological risks and safety assessments.

Toxicology Research is a distinguished journal dedicated to advancing the field of toxicology through the dissemination of high-quality research. Published by Oxford University Press, this UK-based journal focuses on critical aspects of toxicology and mutagenesis, highlighting both environmental and pharmacological implications. With an ISSN of 2045-452X and an E-ISSN of 2045-4538, it serves as a valuable resource for researchers, professionals, and students alike. Currently categorized in the Q3 quartile for Health, Toxicology and Mutagenesis, as well as Toxicology in 2023, Toxicology Research maintains a visible presence in Scopus rankings, positioning itself within the targeted professional community. Although the journal operates without open access options, its importance in contributing to scientific discussions and policy formation is undeniable. Covering content from 2012 to 2024, it continues to provide insights into contemporary toxicological challenges, thereby fostering interdisciplinary collaborations and informing best practices in health and safety.

TOXICOLOGY AND APPLIED PHARMACOLOGY, published by Academic Press, Inc. Elsevier Science, stands as a leading journal in the domains of toxicology and pharmacology, with its establishment dating back to 1959. With an impact factor reflecting its academic rigor and relevance, this journal is classified in the Q2 quartile for both pharmacology and toxicology categories, underscoring its significance in the scientific community. It ranks #34 out of 133 in Toxicology and #95 out of 313 in Pharmacology according to Scopus, placing it within the 74th and 69th percentiles, respectively. The journal aims to disseminate quality research that drives advancements in understanding the interactions of drugs and toxic substances within biological systems. Researchers and professionals are invited to contribute and engage with a broad spectrum of articles that cover mechanistic studies, risk assessment, and innovative therapeutic strategies. Although the journal does not offer open access, it continues to be a crucial resource for those who seek to navigate the complex interface of drugs and their toxicological implications.

Molecular & Cellular Toxicology, published by the Korean Society Toxicogenomics & Toxicoproteomics (KSTT), is a significant journal in the field of toxicology, providing crucial insights into molecular mechanisms underlying toxic responses. With an ISSN of 1738-642X and E-ISSN 2092-8467, this journal serves as a vital platform for researchers, professionals, and students interested in the latest findings and advancements in toxicology, health, and environmental science. Although it operates under a subscription model, it maintains rigorous peer review standards, contributing to its respectable Q3 classification in Health, Toxicology and Mutagenesis, and its Q2 standing in Pharmacology, Toxicology, and Pharmaceutics. The journal, intersecting with innovative aspects of pharmacology and public health, aims to foster a deeper understanding of toxicological impacts on cellular processes and overall health. Located in Germany and supported by a dedicated editorial board, Molecular & Cellular Toxicology stands out in the academic community, encouraging interdisciplinary discourse and collaboration to address critical toxicological challenges. Engage with us for cutting-edge research that informs and shapes the future of toxicological science.

Environmental Toxicology and Pharmacology, published by Elsevier, is a leading journal dedicated to advancing our understanding of the effects of environmental pollutants on biological systems. With an ISSN of 1382-6689 and an E-ISSN of 1872-7077, this journal covers a wide range of studies related to toxicology, pharmacology, and environmental health. The journal is classified as Q2 in key categories such as Health, Toxicology and Mutagenesis and Medicine (miscellaneous), and sits impressively in Q1 for Toxicology, reflecting its strong impact in the field. As of 2023, it ranks #30 out of 133 in Toxicology and #40 out of 148 in Health, indicating its high relevance and contribution to research. While the journal is not currently open access, it remains a pivotal resource for researchers, professionals, and students seeking to explore the intricacies of environmental health effects. Its commitment to publishing high-quality peer-reviewed research positions it as a crucial platform for scientific dialogue and discovery.

Toxin Reviews is a premier academic journal focused on the critical field of Toxicology, published by Taylor & Francis Inc. Established with an aim to foster research and disseminate knowledge, this journal has been pivotal since its inception in 1982 and continues to be a leading platform for both emerging and established researchers. With an impressive impact factor and ranked in the 75th percentile among its peers in the Scopus categories, it serves as an essential resource for scientists, practitioners, and students interested in understanding the complexities of toxins and their effects on health. The journal provides an Open Access platform, enhancing visibility and accessibility of research findings to a broader audience. Covering a wide scope, Toxin Reviews plays a vital role in bridging gaps between toxicological research and practical applications, ensuring that rigorous scientific inquiry translates into real-world solutions.

Toxicological Research is a prominent academic journal dedicated to advancing the field of toxicology through rigorous exploration and innovative research. Published by the Korean Society of Toxicology, this journal serves as a vital resource for researchers, professionals, and students engaged in environmental science, pharmacology, and toxicology. With an ISSN of 1976-8257 and an E-ISSN of 2234-2753, Toxicological Research highlights significant findings and discussions in the realm of health, toxicology, and mutagenesis. Although not an open-access journal, it maintains a solid reputation as evidenced by its Q3 ranking in both health-related toxicology and general toxicology categories for 2023. The journal covers a broad spectrum of topics from fundamental research to applied toxicology and provides a unique platform for the dissemination of knowledge in a field that is increasingly relevant in today’s society. With an anticipated convergence period from 2008 to 2024, Toxicological Research continues to contribute vital insights to understanding the implications of toxic substances on health and the environment.

Drug and Chemical Toxicology is a well-respected journal in the fields of toxicology, pharmacology, and public health, published by Taylor & Francis Ltd. Since its inception in 1978, this journal has diligently explored the effects and mechanisms of chemical exposures on health and the environment, fulfilling a crucial role in advancing scientific understanding and safeguarding public health. The journal is indexed across prestigious databases and features an impressive array of articles categorized within the Q2 and Q3 quartiles across various categories in 2023, reflecting its significance in Chemical Health and Safety as well as Environmental and Occupational Health disciplines. With an extensive reach and a focus on interdisciplinary research, Drug and Chemical Toxicology offers a rich repository of original research, reviews, and methodological advancements, catering to a diverse audience of researchers, professionals, and students dedicated to the betterment of safety and health standards. Although not an open-access publication, its articles are widely accessible to the academic community, ensuring that critical innovations and insights are shared for the greater good.

TOXICOLOGY IN VITRO is a premier journal published by PERGAMON-ELSEVIER SCIENCE LTD, focusing on the latest advancements in the field of toxicology, particularly through in vitro methodologies. With an ISSN of 0887-2333 and an E-ISSN of 1879-3177, this journal serves as a critical platform for researchers aiming to disseminate their findings in toxicology, emphasizing innovative approaches and applications in pharmacology and toxicology. Featuring a commendable impact factor and classified in the second quartile (Q2) for both Medicine (miscellaneous) and Toxicology in 2023, the journal holds a significant position within the academic community, ranking 41st out of 133 in the Toxicology category according to Scopus, representing the 69th percentile. Despite being a subscription-based publication, it continuously attracts submissions from leading scientists worldwide, fostering a vibrant exchange of scientific knowledge. Since its inception in 1987, TOXICOLOGY IN VITRO has consistently aimed to enhance understanding of toxicological challenges, making it an invaluable resource for professionals, students, and researchers dedicated to developing safer pharmaceuticals and understanding the biological pathways influenced by potential toxic agents.